COVID vaccinations: questions and answers about the rollout in North Yorkshire - NHS North Yorkshire CCG
Homologous and Heterologous Covid-19 Booster Vaccinations | NEJM
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial - The Lancet
UC Davis and Pfizer partner on two new COVID-19 booster vaccine clinical trials
Safety and immunogenicity of a bivalent SARS-CoV-2 protein booster vaccine, SCTV01C, in adults previously vaccinated with mRNA vaccine: a randomized, double-blind, placebo-controlled phase 1/2 clinical trial - eBioMedicine
Getting a Flu Vaccine and a COVID-19 Vaccine at the Same Time | CDC
Monitoring Visits in Clinical Trials
Bivalent Omicron BA.1–Adapted BNT162b2 Booster in Adults Older than 55 Years | NEJM
How To Improve Patient Recruitment In Clinical Trials? | Credevo Articles
Immunogenicity and safety of NVSI-06-07 as a heterologous booster after priming with BBIBP-CorV: a phase 2 trial | Signal Transduction and Targeted Therapy
Adopting a New Agile Approach to CRO Clinical Trial Management - Clinical Trial Services, UK | PHARMExcel
NIH begins clinical trial evaluating second COVID-19 booster shots in adults | National Institutes of Health (NIH)
Protocol for a multicentre randomised controlled trial examining the effects of temporarily pausing Bruton tyrosine kinase inhibitor therapy to coincide with SARS-CoV-2 vaccination and its impact on immune responses in patients with
Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial - The Lancet
FDA will not require clinical trial data to authorize redesigned COVID boosters -official | Reuters
Antibody persistence and immune memory response following primary vaccination and boosting with live attenuated SA 14-14-2 Japanese encephalitis vaccine (CD-JEV) in Bangladesh: A phase 4 open-label clinical trial - ScienceDirect
COVID-19 Booster Vaccine Study | Suburban Hospital | Johns Hopkins Medicine
Participants sought for COVID-19 vaccine trial for booster and variant protection
Safety and immunogenicity of seven COVID-19 vaccines as a third dose ( booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV- BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial -
Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial - The Lancet
Virology Research Clinic - University of Washington
Coronavirus information
Coronavirus (COVID-19) Vaccines | CardioSmart – American College of Cardiology
Quadrivalent meningococcal tetanus toxoid-conjugate booster vaccination in adolescents and adults: phase III randomized study | Pediatric Research
Frontiers | Review of Clinical Trials of COVID-19 Vaccination Booster in SARS-CoV-2 Variants Era: To Take It or Not To Take It
COVID-19 Boosters: Why You Should Schedule One Now
Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of Age | NEJM
